S5G Therapeutics Secured NIH Funding for Fuchs Dystrophy
The startup aims to prevent corneal blindness by targeting endothelial cell death.
Live Poll
Should the federal government prioritize funding for private medical research startups?
U.S. Biotech
Recent news
October 6, 2026
Natco Pharma Increased Investment in eGenesisThe pharmaceutical company bolstered its stake to $24.7 million to support ongoing porcine organ transplant research.
October 6, 2026
Court Halted Sale of Accord Biosimilar DrugA federal court blocked the launch of BAT2506 while patent litigation between Janssen and the manufacturers proceeds.
October 5, 2026
Stem Cell Industry Sought FDA Regulatory ApprovalAdvocates have begun pushing for clear federal pathways to shift stem cell therapies from the grey market to commercial use.
October 5, 2026
Patent Issued for Forazapadin Muscle Repair DrugA new composition of matter patent secures intellectual property for an AAK1-targeting therapy through 2044.
October 5, 2026
Oncotelic Therapeutics Launched BIO REBOOT PlatformThe initiative leverages AI-driven literature aggregation to help researchers generate testable oncology hypotheses.
October 5, 2026
FDA Accepted Rani Therapeutics Into Technology ProgramThe agency’s Emerging Technology Program will now provide regulatory feedback on the company’s oral pill platform.
October 5, 2026
Eli Lilly Expanded Gate Bioscience PartnershipThe pharmaceutical giant increased its collaboration by $870 million to target additional protein-driven diseases.
October 5, 2026
Marea Therapeutics Launched Phase 2 Acromegaly TrialThe study evaluates a monoclonal antibody designed to reduce IGF-1 levels in patients with excess growth hormone.
October 5, 2026
Aligos Will Present Hepatitis Research in DenverThe company will share data on antiviral candidates at The Liver Meeting this November.
October 5, 2026
Kymanox Launched Searchable Drug Delivery PlatformThe new KymaBridge portal centralizes technical data for autoinjectors and other drug-delivery devices.